A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Amgen Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 611,410 shares of AMGN stock, worth $162 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
611,410
Previous 611,410 -0.0%
Holding current value
$162 Million
Previous $197 Million -0.0%
% of portfolio
0.6%
Previous 0.6%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$309.38 - $337.38 $29.2 Million - $31.9 Million
94,524 Added 18.29%
611,410 $197 Million
Q2 2024

Jul 29, 2024

BUY
$262.75 - $319.31 $63 Million - $76.5 Million
239,622 Added 86.42%
516,886 $162 Million
Q1 2024

Apr 25, 2024

BUY
$268.87 - $324.56 $191,166 - $230,762
711 Added 0.26%
277,264 $78.8 Million
Q4 2023

Jan 30, 2024

BUY
$255.7 - $288.46 $27.2 Million - $30.7 Million
106,374 Added 62.51%
276,553 $79.7 Million
Q3 2023

Oct 25, 2023

SELL
$218.65 - $271.46 $5.65 Million - $7.02 Million
-25,856 Reduced 13.19%
170,179 $45.7 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $16.8 Million - $19.9 Million
78,542 Added 66.85%
196,035 $43.5 Million
Q1 2023

May 08, 2023

SELL
$225.79 - $275.2 $11.1 Million - $13.5 Million
-49,131 Reduced 29.49%
117,493 $28.4 Million
Q4 2022

Feb 01, 2023

SELL
$229.03 - $291.01 $2.08 Million - $2.65 Million
-9,099 Reduced 5.18%
166,624 $43.8 Million
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $6.41 Million - $7.23 Million
28,552 Added 19.4%
175,723 $39.6 Million
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $993,667 - $1.11 Million
-4,307 Reduced 2.84%
147,171 $35.8 Million
Q1 2022

Apr 21, 2022

SELL
$219.27 - $242.57 $310,705 - $343,721
-1,417 Reduced 0.93%
151,478 $36.6 Million
Q4 2021

Feb 01, 2022

SELL
$198.88 - $227.6 $5.3 Million - $6.07 Million
-26,662 Reduced 14.85%
152,895 $34.4 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $1.41 Million - $1.65 Million
-6,633 Reduced 3.56%
179,557 $38.2 Million
Q2 2021

Jul 30, 2021

SELL
$233.58 - $259.14 $1.53 Million - $1.69 Million
-6,531 Reduced 3.39%
186,190 $45.4 Million
Q1 2021

May 03, 2021

SELL
$221.91 - $258.6 $3.85 Million - $4.48 Million
-17,341 Reduced 8.26%
192,721 $48 Million
Q4 2020

Jan 28, 2021

BUY
$216.38 - $257.67 $202,531 - $241,179
936 Added 0.45%
210,062 $48.3 Million
Q3 2020

Nov 06, 2020

SELL
$234.65 - $260.95 $1.33 Million - $1.48 Million
-5,658 Reduced 2.63%
209,126 $53.2 Million
Q2 2020

Jul 28, 2020

SELL
$197.81 - $242.74 $9.71 Million - $11.9 Million
-49,067 Reduced 18.6%
214,784 $50.7 Million
Q1 2020

May 06, 2020

BUY
$182.24 - $241.7 $941,634 - $1.25 Million
5,167 Added 2.0%
263,851 $53.5 Million
Q4 2019

Jan 21, 2020

BUY
$189.21 - $243.2 $2.45 Million - $3.15 Million
12,959 Added 5.27%
258,684 $62.4 Million
Q3 2019

Oct 18, 2019

SELL
$174.11 - $208.62 $1.46 Million - $1.74 Million
-8,357 Reduced 3.29%
245,725 $47.6 Million
Q2 2019

Jul 30, 2019

SELL
$166.7 - $195.41 $830,832 - $973,923
-4,984 Reduced 1.92%
254,082 $46.8 Million
Q1 2019

Apr 29, 2019

SELL
$180.87 - $203.88 $1.43 Million - $1.61 Million
-7,900 Reduced 2.96%
259,066 $49.2 Million
Q4 2018

Jan 25, 2019

BUY
$178.4 - $208.25 $10.9 Million - $12.7 Million
61,113 Added 29.69%
266,966 $52 Million
Q3 2018

Nov 09, 2018

BUY
$185.29 - $208.89 $5.04 Million - $5.68 Million
27,181 Added 15.21%
205,853 $42.7 Million
Q2 2018

Aug 06, 2018

SELL
$166.05 - $186.51 $1.3 Million - $1.46 Million
-7,825 Reduced 4.2%
178,672 $33 Million
Q1 2018

May 03, 2018

SELL
$169.43 - $198.0 $13.5 Million - $15.8 Million
-79,919 Reduced 30.0%
186,497 $31.8 Million
Q4 2017

Jan 31, 2018

SELL
$168.79 - $188.59 $6.68 Million - $7.46 Million
-39,567 Reduced 12.93%
266,416 $46.3 Million
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $51.2 Million - $58.4 Million
305,983
305,983 $57.1 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.